. 2017 Jun 19;14(2):2393–2398. doi: 10.3892/ol.2017.6410

Table III.

Univariate analysis and multivariate analysis identifies factors affecting disease-free survival of patients with breast cancer.

	Univariate analysis			Multivariate analysis

Variables	RR	95% CI	P-value	RR	95% CI	P-value
TNFR2	2.616	1.185–5.775	0.017^a	2.622	1.031–6.668	0.043^a
Age	2.723	1.258–5.895	0.011^a	2.033	0.797–5.19	0.138
Menopausal status	4.324	1.916–9.759	<0.0001^a	3.41	1.103–10.544	0.033^a
Family history	0.875	0.301–2.541	0.806	1.232	0.374–4.054	0.732
Tumor size	0.344	0.144–0.82	0.016^a	0.847	0.28–2.561	0.769
Lymph involvement	1.351	0.625–2.921	0.444	0.73	0.26–2.054	0.551
Clinical stage	0.328	0.15–0.714	0.005^a	0.442	0.158–1.241	0.121
Pathological grade	0.257	0.111–0.595	0.002^a	0.596	0.225–1.574	0.296
Histological type	1.407	0.466–2.349	0.912	0.949	0.393–2.291	0.908
ER, PR and HER2	2.856	1.318–6.187	0.008^a	0.615	0.238–1.588	0.315

P<0.05. TNFR2, tumor necrosis factor receptor 2; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; RR, relative risk; CI, confidence interval.